Many patients with overweight or obesity discontinue GLP-1 receptor agonist therapy within 1 year, with higher discontinuation rates seen for those without type 2 diabetes.

TWO sizeable sisters say they are “living proof” their town is the unhealthiest place to live in the UK. The self-confessed ...

Children with overweight and obesity experienced notable improvements in health outcomes after participating in a lifestyle ...

As obesity rates rise across the U.S., a new study from UnitedHealthcare and the Health Action Council examines the financial ...

Obesity is more than just a diet and exercise issue; it's deeply intertwined with psychological and social factors. Experts ...

And these programs are important for children who don’t yet have overweight or obesity by teaching and reinforcing healthy behaviors. As senators scrutinize President Donald Trump’s nominees ...

Having overweight or obesity can further restrict airways, worsening the condition. OSA can also cause you to gain weight because of its negative effects on your day-to-day functioning and hormone ...

Discover how teens' circadian rhythms influence late-day eating and obesity risk. Learn about biological clocks' impact on ...

Children as young as ten have had hip replacements on the NHS because they are so overweight, alarming figures show. Britain's child obesity crisis has been laid bare after it emerged at least ...

CHILDREN as young as ten have had hip replacements on the NHS because they are so fat, shock figures show. They are going under the knife as childhood obesity levels soar, with one in three now ...

Greaux Healthy—a public service initiative powered by Pennington Biomedical Research Center, in partnership with the State of ...

HealthDay News — Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within one year, with higher discontinuation rates seen for those without ...